Stanford Study Shows Americans Inhaling Unintended Substances

Jun.02.2022
Stanford Study Shows Americans Inhaling Unintended Substances
A new study from Stanford University reveals that Americans are vaping non-nicotine substances, which can harm the lungs.

According to a report by FUTURITY website, a new study conducted by Stanford University reveals that Americans are consuming substances they never thought of inhaling before, including melatonin, essential oils, tea, vitamins, caffeine, and other non-nicotine substances.

 

This survey questioned the usage habits of over 6,000 adolescents, young adults, and adults aged 13-40. It is the first nationwide sample survey on the intake of non-nicotine products.

 

Scientists say that while some non-nicotine substances may be safe for ingestion, inhaling them through vaporization may harm the lungs. Chemicals, solvents, and flavors found in non-nicotine vaping products also exist in nicotine vaping products and have been shown to have harmful effects unrelated to nicotine.

 

According to Bonnie Halpern-Felsher, a professor of pediatrics at Stanford University School of Medicine and a senior author of a paper on the online edition of the Journal of the American Medical Association, "Our most striking finding was that nearly 14% of youths and 24% of young adults had used non-nicotine electronic cigarettes.

 

Non-nicotine electronic cigarettes currently evade regulation by the Food and Drug Administration for nicotine e-cigarettes or intake supplements, which means there are no restrictions on the equipment, ingredients, or marketing of these products. Additionally, there is no age limit for purchasing these products. According to Halpern-Felsher, many sellers make unfounded health claims, making electronic cigarettes appear safe to both youth and adults, despite their safety never being tested.

 

According to Halpern-Felsher, "Anything that is purchased, heated, and inhaled without a prescription is harmful to your lungs.

 

Investigation reveals

 

Researchers surveyed teenagers, young adults, and adults living across the United States, focusing on four age groups: 13-17, 18-20, 21-24, and 25-40. These groups represent different stages of development: early adolescence, young adulthood below the legal age for nicotine e-cigarette sales, prefrontal brain maturation during young adulthood, and adulthood. Participants' gender, race, and ethnicity were representative of the US population.

 

Participants answered questions about their use of non-nicotine electronic cigarettes, nicotine-containing electronic cigarettes, and combustible cigarettes. The survey asked if participants had ever used these products, if they had used them recently, and the timing of their first use of each product. The survey also included questions about usage patterns, specific brands, preferred flavors, and ingredients used in non-nicotine vaping devices.

 

Overall, approximately 26% of participants reported trying non-nicotine e-cigarettes, with nearly 17% reporting use within the past 30 days and approximately 12% within the past 7 days. Usage varied according to age, with the 21-24 year old group reporting the highest proportion of non-nicotine use (approximately 38%), followed by the 25-40 year old group at nearly 33%.

 

Approximately 14% of 13 to 17-year-olds and 24% of 18 to 20-year-olds have reported trying non-nicotine electronic cigarettes, with more than half of those individuals using these devices multiple times. On average, participants reported trying non-nicotine e-cigarettes at a younger age than nicotine e-cigarettes, raising concerns that non-nicotine devices could be a pathway to using nicotine-containing products.

 

What substances are people inhaling?

 

Many young survey participants are unaware of what they are vaping. Approximately 24% of teenagers aged 13 to 17 and 19% of young adults aged 18 to 20 reported that they do not know what is in the non-nicotine e-cigarettes they use.

 

Popular substances for consumption among teenagers and young people include tetrahydrocannabinol (THC), an active compound found in marijuana. Other substances include melatonin, cannabidiol (CBD), a non-psychoactive derivative of marijuana, essential oils, caffeine, and tea.

 

Among adults aged 25-40, caffeine, vitamin B, tea, and tetrahydrocannabinol are all popular. A complete list of substances found in non-nicotine electronic cigarettes includes vitamin C, lavender, essential oils, propylene glycol, glycerin, and other flavorings.

 

Halpern-Felsher stated that while the use of marijuana compounds isn't surprising, the popularity of other substances is unexpected and concerning.

 

The Food and Drug Administration has designated certain chemicals added to food, including vitamins and some flavorings, as "generally recognized as safe." However, this is not always the case.

 

According to Halpern-Felsher, the designation of GRAS (an indicator used by the US FDA to evaluate safety of food additives) means that certain things are safe to consume or use as a skin cream. However, there is a significant difference when it comes to inhaling aerosols produced by heating substances. This is where it affects your lungs.

 

Halpern-Felsher emphasized that the safety and potential risks or side effects of inhaling these substances are still not clear. Furthermore, non-nicotine e-cigarettes share common ingredients with nicotine-containing e-cigarettes, such as propylene glycol, glycerin, and flavoring compounds, all of which are known to be harmful to the lungs.

 

Unknown dangers

 

Halpern-Felsher has stated that for several common substances that are smoked, our existing knowledge of their chemical properties indicates that they pose harm to the lungs, and consumers should remain cautious.

 

She said, 'We really need toxicologists and other scientists to help us understand the impact of these chemicals on our bodies and by what mechanisms.' For example, she noted that excessive amounts of vitamins can have toxic effects. Pulmonary surfactants are oily substances produced by the body to lubricate lung air sacs. Inhaling evaporated fatty substances, such as essential oils, glycerin (a common ingredient in all e-cigarettes), and aromatic compounds, may interfere with lung function.

 

The message for everyone, especially young people, is that any inhaled aerosol, except for medication prescribed by a doctor (such as asthma treatment), could potentially be dangerous.

 

Halpern-Felsher stated, "Maintaining the health of our lungs has never been as critical as it is now during the COVID-19 pandemic.

 

She hopes that these findings will stimulate policy changes to better regulate the electronic cigarette industry, especially in terms of protecting youth.

 

We cannot allow non-nicotine products to be available for purchase in the open market anymore, especially considering the fact that young people are sharing and inhaling them without knowing what substances they contain. We need regulation and labelling measures to ensure that these products do not end up in the hands of young people.

 

Source: FUTURITY.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
How Investors Are Repricing the Global Tobacco Industry as Nicotine Markets Shift
How Investors Are Repricing the Global Tobacco Industry as Nicotine Markets Shift
How are investors reassessing the global tobacco industry as nicotine markets evolve? In an interview with 2Firsts, Charlie Chen, Head of Research at CCB International Securities, forecasts annual growth of 30–50% for nicotine pouches, outpacing vaping and heated tobacco. He examines how regulatory enforcement, shifting market shares and new business models are influencing company valuations. The report also explores differences between multinational tobacco groups and Chinese companies, drawing on insights from the New Approaches Summit on profitability, investment strategies and industry consolidation.
Nov.11
UK Extends Age-18 Rules to Zero-Nicotine Vapes and Nicotine Pouches From Oct. 29, Bans Vending Machines and Promotional Giveaways
UK Extends Age-18 Rules to Zero-Nicotine Vapes and Nicotine Pouches From Oct. 29, Bans Vending Machines and Promotional Giveaways
Key provisions of the UK's Tobacco and Vapes Act 2026 will take effect on Oct. 29, extending an age-18 sales restriction to all vaping and non-medicinal nicotine products. In England, Wales and Northern Ireland, the change brings zero-nicotine vapes within statutory age-of-sale rules and also covers products including nicotine pouches, strips and pearls. The law will also prohibit proxy purchasing for under-18s, consumer-facing vending machines, promotional giveaways and substantial discounts intended to promote vaping and nicotine products.
Regulations
Oct.10
Special report|Indonesia's Vape Industry Has 200 Manufacturers and $1.7 Billion in Investment. Could a Regulatory Divide Derail Its Rise as the World's No. 2 Manufacturing Hub After Shenzhen?
Special report|Indonesia's Vape Industry Has 200 Manufacturers and $1.7 Billion in Investment. Could a Regulatory Divide Derail Its Rise as the World's No. 2 Manufacturing Hub After Shenzhen?
Indonesia's Ministry of Industry said at a November 3, 2026, policy forum that the country has about 200 electronic cigarette companies, Rp31 trillion (approximately $1.71 billion) in cumulative industry investment and around 100,000 jobs across the supply chain. The National Narcotics Agency is seeking a comprehensive ban on vape use and circulation, while the industry ministry favors tighter import, product-standard and distribution controls. Indonesia exported approximately $518 million in vaping products in 2025, and Chinese manufacturers including Smoore, GEEKVAPE and Jinjia Group have established local operations. An international logistics specialist interviewed by 2Firsts said more Chinese vape companies began production in Indonesia from the second half of 2025, accompanied by increased shipments of manufacturing equipment and investment in logistics facilities. The regulatory debate comes as Indonesia expands its role in international vaping manufacturing.
Special Report
Nov.05
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU finance ministers failed to reach agreement on tobacco excise reform at the November 9, 2026 Economic and Financial Affairs Council (ECOFIN) meeting in Brussels. The Irish Council presidency's compromise secured support from 26 of the EU's 27 member states, but Malta withheld consent, preventing the Council from reaching a general approach requiring unanimity. The reform would raise minimum taxes on conventional tobacco and bring e-cigarette liquids, heated tobacco and nicotine pouches into a common EU minimum excise framework. Finland and Estonia accepted further concessions during the meeting, while the presidency proposed separating the inclusion of nicotine pouches in the framework from setting their precise minimum tax rates. Another compromise would allow ten qualifying member states until 2036 to meet certain tobacco excise requirements. Ireland intends to continue negotiations in December.
Regulations
Nov.11